You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SARS-CoV2

Showing 51 - 75 of 5,886
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster

Terminated
  • Anti-SARS-CoV-2 Antibody Response
  • blood and saliva samples will be taken
  • Graz, Austria
    Medizinische Universität Graz, Klinische Abteilung für Rheumatol
Jan 9, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Ferrara (SARS-Cov-2 infection)

Recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • SARS-Cov-2 infection
  • Ferrara, Italy
    Azienda Ospedaliera Universitaria di Ferrara
Nov 1, 2022

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2

Recruiting
  • Covid19
  • Serologic immunoassays to SARS-CoV-2 antibodies
  • Detroit, Michigan
    Henry Ford Health System
Dec 13, 2022

SARS-CoV-2, Covid-19, Coronavirus Trial in Miami (Xiamen Wiz Biotech Co., Ltd. SARS-CoV-2 Antigen Rapid Test)

Withdrawn
  • SARS-CoV-2
  • +2 more
  • Xiamen Wiz Biotech Co., Ltd. SARS-CoV-2 Antigen Rapid Test
  • Miami, Florida
    D&H National Research Centers INC
Aug 3, 2022

COVID-19 Trial in Shang Qiu (low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell), high-dose Recombinant SARS-CoV-2 Vaccine (CHO

Active, not recruiting
  • COVID-19
  • low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
  • +2 more
  • Shang Qiu, He Nan, China
    Ning ling Center for Disease Control and Prevention
Jan 31, 2023

Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)

Completed
  • Zinc Deficiency
  • Sars-CoV-2 Infection
  • Zinc Acetate
  • Barcelona, Spain
    Hospital del Mar
Mar 18, 2023

COVID-19 Transmission and Morbidity in Malawi

Recruiting
  • SARS CoV 2 Infection
  • SARS CoV 2 Vaccination
    • Boston, Massachusetts
    • +1 more
    Aug 6, 2023

    SARS-CoV-2 Acute Respiratory Disease Trial (Povidone Iodine 5% Soln,Top,Kit)

    Not yet recruiting
    • SARS-CoV-2 Acute Respiratory Disease
    • Povidone Iodine 5% Soln,Top,Kit
    • (no location specified)
    Feb 24, 2023

    COVID-19 Trial in Shanghai (Azvudine, Placebo)

    Recruiting
    • COVID-19
    • Shanghai, Shanghai, China
      Huashan Hospital
    Jan 28, 2023

    Under Invasive Mechanical Ventilation in SARS-CoV-2 &

    Not yet recruiting
    • ARDS Due to Disease Caused by SARS Co-V-2
    • +2 more
      • (no location specified)
      Feb 1, 2023

      Humoral and Cellular Immunity in First-cycle SARS-CoV-2

      Completed
      • SARS CoV 2 Infection
      • COVID-19
      • LIAISON SARS-CoV-2 TrimericS IgG (DiaSorin)
      • +2 more
      • Catanzaro, Italy
        AOU Mater Domini
      Jul 15, 2022

      SARS-CoV-2, Prevention Trial in Chongqing (A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray, A8G6 SARS-CoV-2

      Recruiting
      • SARS-CoV-2
      • Prevention
      • A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray
      • A8G6 SARS-CoV-2 Neutralization Antibody nasal excipient
      • Chongqing, Chongqing, China
        The Second Affiliated Hospital of Chongqing Medical University
      Nov 9, 2023

      T7 and T12 Slices on Mortality in Resuscitation ARDS Caused by

      Not yet recruiting
      • Acute Respiratory Distress Syndrom (SARS-Cov 2)
      • Data collection
      • analysis of thoracic scans
      • (no location specified)
      Oct 21, 2022

      SARS CoV 2 Infection, COVID-19 Trial in Brussels (Humoral immunity)

      Enrolling by invitation
      • SARS CoV 2 Infection
      • COVID-19
      • Humoral immunity
      • Brussels, Belgium
        Sciensano
      Jan 16, 2023

      SARS-CoV-2, Safety, Immunotoxicity Trial in Wuhan (one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006), Cellular Immunity,

      Not yet recruiting
      • SARS-CoV-2
      • +2 more
      • one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006)
      • +3 more
      • Wuhan, Hubei, China
        Zhongnan Hospital of Wuhan University
      Aug 9, 2022

      Covid19, SARS-COV-2 Infection Trial (DWJ1248, Placebo)

      Terminated
      • Covid19
      • SARS-COV-2 Infection
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Dec 4, 2022

      Lipids in SARS-CoV2 Infection - In Search of Atherogenic

      Recruiting
      • SARS-CoV2 Infection
      • Blood sample of 30 ml
      • Dijon, France
        Chu Dijon Bourgogne
      Jul 25, 2022

      COVID-19 Trial in Madrid (Aerobic plus strength group, Aerobic group)

      Not yet recruiting
      • COVID-19
      • Aerobic plus strength group
      • Aerobic group
      • Madrid, Spain
        David Fernández
      Dec 27, 2022

      SARS Cov 2 Vaccination in Juvenile Idiopathic Arthritis

      Recruiting
      • SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis
        • Nantes, Loire-Atlantique, France
          CHU de Nantes
        Sep 16, 2022

        Against Sars-Cov2 Virus in Received EU-approved COVID-19

        Completed
        • SARS-CoV2 Infection
        • Vaccine Reaction
        • Approved vaccines against Sars-Cov2
        • Patras, Greece
          University Hospital of Patras
        Jun 2, 2022

        SARS-CoV2 Infection Trial in Renton (HDT-301)

        Active, not recruiting
        • SARS-CoV2 Infection
        • HDT-301
        • Renton, Washington
          Rainier Clinical Research
        Jan 16, 2023

        Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus

        Not yet recruiting
        • COVID-19
        • Diabete Mellitus
        • Measure of physiologic parameters
        • San Antonio, Texas
          Texas Diabetes Institute - University Health System
        May 17, 2023

        Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

        Recruiting
        • SARS-CoV-2
        • SPIKEVAX
        • New York, New York
          Aetion, Inc
        Nov 8, 2023

        SARS-COV2 Pandemic Serosurvey and Blood Sampling

        Completed
        • SARS-COV2 Virus
          • Birmingham, Alabama
          • +2 more
          Jul 6, 2022

          COVID-19 Trial in Chicago (Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo)

          Active, not recruiting
          • COVID-19
          • Experimental: Primary Cohort
          • Placebo Comparator: Primary Cohort - Placebo
          • Chicago, Illinois
            University of Chicago
          Aug 24, 2023